Form D · Other Investment Fund
Pleasanton Pharma Ventures I, L.P.
Pleasanton, CA · CIK 0001629697
Offering snapshot reported Jan 6, 2015 · SEC filing
- Reported sold
- $12.8M Offering amount: $200M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 23, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2015 | Initial | $12,800,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $3.5M (estimated)
- Form D file number
- 021-231504
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Harpeth Securities, LLC | 109821 |
Source: Form D, filed Jan 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce Bouchard | Director, Executive |
| David Lilley | Director, Executive |
| Jorge Puente | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
5000 Hopyard Road, Suite 330
Pleasanton, CA, 94588
Pleasanton, CA, 94588